These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31378765)

  • 1. Human plasma and liver concentrations of styrene estimated by combining a simple physiologically based pharmacokinetic model with rodent data.
    Miura T; Uehara S; Nakazato M; Kusama T; Toda A; Kamiya Y; Murayama N; Shimizu M; Suemizu H; Yamazaki H
    J Toxicol Sci; 2019; 44(8):543-548. PubMed ID: 31378765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-State Human Pharmacokinetics of Monobutyl Phthalate Predicted by Physiologically Based Pharmacokinetic Modeling Using Single-Dose Data from Humanized-Liver Mice Orally Administered with Dibutyl Phthalate.
    Miura T; Uehara S; Mizuno S; Yoshizawa M; Murayama N; Kamiya Y; Shimizu M; Suemizu H; Yamazaki H
    Chem Res Toxicol; 2019 Feb; 32(2):333-340. PubMed ID: 30652481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma, liver, and kidney exposures in rats after oral doses of industrial chemicals predicted using physiologically based pharmacokinetic models: A case study of perfluorooctane sulfonic acid.
    Kamiya Y; Yanagi M; Hina S; Shigeta K; Miura T; Yamazaki H
    J Toxicol Sci; 2020; 45(12):763-767. PubMed ID: 33268676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.
    Tsukada A; Suemizu H; Murayama N; Takano R; Shimizu M; Nakamura M; Yamazaki H
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):316-24. PubMed ID: 23395687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling.
    Yamashita M; Suemizu H; Murayama N; Nishiyama S; Shimizu M; Yamazaki H
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):214-21. PubMed ID: 25016177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Profiles of Tetrabromobisphenol A in Humans Extrapolated from Humanized-Liver Mouse Data Using a Simplified Physiologically Based Pharmacokinetic Model.
    Miura T; Uehara S; Shigeta K; Yoshizawa M; Kamiya Y; Murayama N; Shimizu M; Suemizu H; Yamazaki H
    Chem Res Toxicol; 2021 Feb; 34(2):522-528. PubMed ID: 33198470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of concentrations of styrene-7,8-oxide in rats and humans resulting from exposure to styrene or styrene-7,8-oxide and potential genotoxicity.
    Filser JG; Gelbke HP
    Toxicol Lett; 2016 Apr; 247():11-28. PubMed ID: 26851640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forward and reverse dosimetry for aniline and 2,6-dimethylaniline in humans extrapolated from humanized-liver mouse data using simplified physiologically based pharmacokinetic models.
    Miura T; Uehara S; Shimizu M; Suemizu H; Yamazaki H
    J Toxicol Sci; 2022; 47(12):531-538. PubMed ID: 36450497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic model.
    Shimizu M; Yamazaki H
    J Toxicol Sci; 2017; 42(4):485-490. PubMed ID: 28717107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene.
    Verner MA; McDougall R; Johanson G
    Toxicol Lett; 2012 Sep; 213(2):299-304. PubMed ID: 22677344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling.
    Kirman CR; Sweeney LM; Meek ME; Gargas ML
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):345-67. PubMed ID: 14623485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Hepatic Concentrations of Bromobenzene, 1,2-Dibromobenzene, and 1,4-Dibromobenzene in Humanized-Liver Mice Predicted Using Simplified Physiologically Based Pharmacokinetic Models as Putative Markers of Toxicological Potential.
    Miura T; Shimizu M; Uehara S; Yoshizawa M; Nakano A; Yanagi M; Kamiya Y; Murayama N; Suemizu H; Yamazaki H
    Chem Res Toxicol; 2020 Dec; 33(12):3048-3053. PubMed ID: 33283517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling.
    Yamazaki H; Horiuchi K; Takano R; Nagano T; Shimizu M; Kitajima M; Murayama N; Shono F
    Int J Environ Res Public Health; 2010 Sep; 7(9):3406-21. PubMed ID: 20948932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung.
    Csanády GA; Kessler W; Hoffmann HD; Filser JG
    Toxicol Lett; 2003 Feb; 138(1-2):75-102. PubMed ID: 12559694
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kamiya Y; Handa K; Miura T; Yanagi M; Shigeta K; Hina S; Shimizu M; Kitajima M; Shono F; Funatsu K; Yamazaki H
    Chem Res Toxicol; 2021 Feb; 34(2):507-513. PubMed ID: 33433197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Hepatic Concentrations of Chemicals after Virtual Oral Administrations Extrapolated Using Rat Plasma Data and Simple Physiologically Based Pharmacokinetic Models.
    Kamiya Y; Otsuka S; Miura T; Takaku H; Yamada R; Nakazato M; Nakamura H; Mizuno S; Shono F; Funatsu K; Yamazaki H
    Chem Res Toxicol; 2019 Jan; 32(1):211-218. PubMed ID: 30511563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human plasma concentrations of trimethylamine N-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice.
    Shimizu M; Suemizu H; Mizuno S; Kusama T; Miura T; Uehara S; Yamazaki H
    J Toxicol Sci; 2018; 43(6):387-393. PubMed ID: 29877215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiles for the pyrrolizidine alkaloid neopetasitenine and its metabolite petasitenine in humans extrapolated from rat in vivo and in vitro data sets using a simplified physiologically based pharmacokinetic model.
    Yanagi M; Kamiya Y; Murayama N; Banju K; Shimizu M; Yamazaki H
    J Toxicol Sci; 2021; 46(9):391-399. PubMed ID: 34470991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Concentration Profiles for Hepatotoxic Pyrrolizidine Alkaloid Senkirkine in Humans Extrapolated from Rat Data Sets Using a Simplified Physiologically Based Pharmacokinetic Model.
    Kamiya Y; Miura T; Kato A; Murayama N; Shimizu M; Yamazaki H
    Drug Metab Bioanal Lett; 2022; 15(1):64-69. PubMed ID: 34931973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of safe health-based exposure limits for potential consumer exposure to styrene migrating into food from food containers.
    Gelbke HP; Banton M; Faes E; Leibold E; Pemberton M; Duhayon S
    Food Chem Toxicol; 2014 Feb; 64():258-69. PubMed ID: 24316211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.